CytomX Therapeutics Competitors and Similar CompaniesClear all
CytomX Therapeutics's competitors and similar companies include Stingray Therapeutics, Forbius and Ablynx.
 CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  Stingray Therapeutics Stingray Therapeutics is a company that specializes in immunotherapy to fight cancer. |  Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | |
Founding Date | Founding Date 2008 | Founding Date 2018 | Founding Date 2011 | Founding Date 2001 |
Type | Type Public | Type Private | Type Subsidiary | Type Subsidiary |
Tags | ||||
Locations | Locations South San Francisco, US HQ | Locations Houston, US HQ | Locations Austin, US HQ Montréal, CA | Locations Gent, BE HQ |
Employees | Employees 15815% increase | Employees 6 | Employees 9 | Employees 156 |
Financial | ||||
Revenue (est.) | Revenue (est.) $101.2m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €85.2m (FY, 2016) |
Net income | Net income ($569k) (FY, 2023) | Net income N/A | Net income N/A | Net income (€1.1m) (FY, 2016) |
Operating ⚠ | ||||
Patents (Foreign) | Patents (Foreign) 4 (FY, 2016) | Patents (Foreign) N/A | Patents (Foreign) N/A | Patents (Foreign) 180 (Q2, 2017) |
Patents (US) | Patents (US) 13 (FY, 2016) | Patents (US) N/A | Patents (US) N/A | Patents (US) 50 (Q2, 2017) |
Funding | ||||
Total funding raised | Total funding raised $ 132.4m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 498.8m |
For sources of this data, please see the company profile
View Company Profiles
Stingray Therapeutics
HQ
Houston, US
Employees
6
Stingray Therapeutics is a company that specializes in immunotherapy to fight cancer.
View companyForbius
HQ
Austin, US
Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
View companyAblynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company